Apellis Pharmaceuticals, Inc.
Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. T…
Biotechnology
US, Waltham [HQ]
Balance Sheet
11 Sheets · Starting from 2023In Million USD. Margins, Growth Rates In %
| Metric | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | 5.00 | 14.00 | 38.00 | 27.00 | 182.00 | 203.00 | 389.00 | 960.00 | 881.00 | 760.00 | 788.00 | |
|
Current
|
5.00 | 14.00 | 38.00 | 27.00 | 182.00 | 202.00 | 373.00 | 917.00 | 824.00 | 719.00 | 766.00 | |
| Cash And Equivalents | 4.00 | 13.00 | 36.00 | 24.00 | 175.00 | 176.00 | 351.00 | 565.00 | 640.00 | 551.00 | 352.00 | |
| Assets | 5.00 | 14.00 | 38.00 | 27.00 | 182.00 | 203.00 | 389.00 | 960.00 | 881.00 | 760.00 | 788.00 | |
| Accounts Receivables (AR) | - - | - - | - - | - - | - - | - - | - - | - - | -10.00 | 2.00 | -198.00 | |
| Inventory | - - | - - | - - | - - | - - | - - | - - | - - | 16.00 | 85.00 | 146.00 | |
| Short Term Investments | - - | - - | - - | - - | - - | - - | - - | 311.00 | 60.00 | 6.00 | 4.00 | |
| Other Current Assets | - - | - - | 2.00 | 2.00 | 1.00 | 1.00 | 1.00 | 26.00 | 70.00 | 36.00 | 61.00 | |
|
Non Current
|
- - | - - | - - | - - | - - | 1.00 | 16.00 | 43.00 | 57.00 | 40.00 | 22.00 | |
| Property, Plant, Equipment (Net) | - - | - - | - - | - - | - - | - - | 15.00 | 24.00 | 26.00 | 24.00 | 21.00 | |
|
Intangible Assets
|
- - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Goodwill | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Long Term Investments | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Other Non Current Assets | - - | - - | - - | - - | - - | 1.00 | - - | 18.00 | 31.00 | 15.00 | 1.00 | |
| Liabilities | - - | 1.00 | 3.00 | 3.00 | 33.00 | 42.00 | 355.00 | 756.00 | 683.00 | 590.00 | 594.00 | |
|
Current
|
- - | 1.00 | 3.00 | 3.00 | 6.00 | 17.00 | 65.00 | 128.00 | 131.00 | 167.00 | 247.00 | |
| Accounts Payable | - - | - - | 1.00 | - - | - - | 6.00 | -1.00 | - - | 10.00 | 18.00 | - - | |
| Short Term Debt | - - | - - | - - | - - | - - | 1.00 | 2.00 | 3.00 | 4.00 | 5.00 | 6.00 | |
| Deferred Revenue | - - | - - | - - | - - | - - | - - | - - | 111.00 | 103.00 | - - | - - | |
| Tax Payable | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Other Current Liabilities | - - | - - | - - | 1.00 | 2.00 | 5.00 | 54.00 | 4.00 | 7.00 | 124.00 | 203.00 | |
|
Non Current
|
- - | - - | - - | - - | 26.00 | 25.00 | 289.00 | 627.00 | 551.00 | 422.00 | 346.00 | |
| Long Term Debt | - - | - - | - - | - - | 26.00 | 25.00 | 154.00 | 374.00 | 206.00 | 107.00 | 93.00 | |
| Leasing Obligations | - - | - - | - - | - - | - - | - - | 14.00 | 18.00 | 21.00 | 19.00 | 11.00 | |
| Deferred Non Current Tax Liabilities | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Other Non Current Liabilities | - - | - - | - - | - - | - - | - - | 134.00 | 253.00 | 345.00 | 315.00 | 253.00 | |
| Equity | 4.00 | 13.00 | 34.00 | 23.00 | 148.00 | 160.00 | 34.00 | 204.00 | 198.00 | 169.00 | 194.00 | |
| Stockholders' Equity | 4.00 | 13.00 | 34.00 | 23.00 | 148.00 | 160.00 | 34.00 | 204.00 | 198.00 | 169.00 | 194.00 | |
| Retained Earnings | -13.00 | -24.00 | -71.00 | -98.00 | -149.00 | -276.00 | -581.00 | -926.00 | -1,656.00 | -2,308.00 | -2,837.00 | |
| Common Stock | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Preferred Stock | 16.00 | 35.00 | 77.00 | 92.00 | - - | - - | - - | - - | - - | - - | - - | |
| Profit | -3.00 | -10.00 | -46.00 | -27.00 | -51.00 | -127.00 | -309.00 | -344.00 | -746.00 | -652.00 | -528.00 | |
| Dividends | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Minority Interest | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Other Stockholders' Equity | 1.00 | 1.00 | 28.00 | 29.00 | 298.00 | 437.00 | 615.00 | 1,131.00 | 1,857.00 | 2,479.00 | 3,035.00 | |
| Loss Other Compr. Income | - - | - - | - - | - - | - - | - - | - - | - - | -2.00 | - - | -3.00 |